Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
Pfizer is conducting a Korean post-marketing surveillance study of ELREXFIO (elranatamab) in adults with multiple myeloma to monitor safety …
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
This entry notes a safety-focused clinical trial of lenalidomide in adults with previously untreated multiple myeloma who are not eligible f…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial of Descartes-15 for relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Home Based Daratumumab Administration for Patients With Multiple Myeloma [Phase 4]
Phase 4 study update on home-based administration of daratumumab for multiple myeloma, with the trial completed and results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients [NA]
A completed clinical trial assessing whether distance Reiki improves quality of life and immune function in multiple myeloma patients underg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: e-Motion : Promoting Emotion Regulation in Chronic Cancer [NA]
A clinical trial update for e-Motion, an emotion regulation program, being studied in patients with metastatic cancer and multiple myeloma; …
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: High Dose Carfilzomib for Newly Diagnosed Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating high-dose carfilzomib in newly diagnosed multiple myeloma has completed enrollment with results posted.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies [Phase 1]
A Phase 1 clinical trial of an in vivo CAR-T therapy for relapsed/refractory hematologic cancers is currently recruiting. The study targets …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A New Study Evaluating the Activity of Modular CAR T for mYeloma [Phase 1]
A Phase 1 study at University College London is evaluating the activity of Modular CAR T therapy in patients with multiple myeloma and is cu…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma [NA]
A completed clinical trial evaluating macrophage-colony stimulating factor as a biomarker for bone lesions in patients with multiple myeloma…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients [Phase 2]
Phase 2 study evaluating post-transplant maintenance therapy with isatuximab plus lenalidomide for high-risk multiple myeloma; currently rec…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Ongoing recruitment for studies evaluating novel treatments to improve renal outcomes in light-chain cast nephropathy, including patients wi…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
This clinical trial update reports ongoing recruitment for a study examining how quantitative and qualitative monocyte characteristics influ…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma [Phase 2]
This report summarizes a Phase 2 clinical trial evaluating outpatient and intermittent dosing of elranatamab for relapsed/refractory multipl…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial [Phase 1, Phase 2]
The AMBUSH trial is a Phase 1/2 study evaluating Bortezomib and Pembrolizumab with or without Pelareorep for relapsed or refractory multiple…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) [NA]
A clinical trial is evaluating a plant-based diet and dietary supplements in people with smoldering multiple myeloma or monoclonal gammopath…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]
A Phase 1 trial evaluating natural killer cell therapy in combination with Interleukin-2 and the TGF-beta receptor I inhibitor vactosertib f…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating an imaging agent, 89Zr-DFO-YS5, for detecting CD46-positive malignancies in multiple myeloma. The study is…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial of belantamab mafodotin as maintenance therapy after salvage autologous hematopoietic cell transplantation in relapse/refrac…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) [Phase 2]
This document provides a status update on a Phase 2 clinical trial evaluating belantamab mafodotin in combination with standard of care for …
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial of Narazaciclib in combination with dexamethasone for relapsed and/or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS approval · 2025-11-10Clinical Trial Update: Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Regeneron reports compassionate-use access for REGN5458 in relapsed or refractory multiple myeloma, and the trial page notes that REGN5458 h…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Sleep Apnea in Patients With MGUS and MM
This clinical trial update describes an ongoing study evaluating sleep apnea in patients with multiple myeloma and monoclonal gammopathy of …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) [Phase 2]
This clinical trial update describes a Phase 2 platform study of belantamab mafodotin as monotherapy and in combination for relapsed/refract…